US Pharm. 2012;37(9):54.

Amneal Pharmaceuticals, LLC, announced that the company is investing $120 million in physical plant capital expenditures from 2012 to 2014 to significantly grow operations at three of its six current U.S. research and development, manufacturing, and distribution facilities. Planned site expansions and infrastructure enhancement projects will create over 500 new jobs in manufacturing, R&D, distribution, and sales at Amneal locations in New York, New Jersey, and Kentucky. The facility enlargements and resulting jobs increase will generate an estimated $21 million per year in additional payroll and other benefits to local economies. The company now employs over 1,100 people in the U.S.